IQVIA Holdings Inc.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solution…
Medical - Diagnostics & Research
US, Durham [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | 16.34 | 73.05 | 62.79 | |
| Graham Fair Price | -20.16 | 35.25 | 44.15 | |
| PEG | 150.45 | -1.01 | 0.40 | |
| Price/Book | 3.63 | 7.14 | 6.89 | |
| Price/Cash Flow | 62.05 | 120.08 | 74.10 | |
| Prices/Earnings | 75.16 | 39.30 | 22.43 | |
| Price/Sales | 12.42 | 12.10 | 10.77 | |
| Price/FCF | 62.05 | 120.08 | 74.10 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | -3.26 | 0.28 | 0.29 | |
| Operating Margin | -2.03 | 0.14 | 0.14 | |
| ROA | -38.35 | 0.01 | 0.02 | |
| ROE | 0.08 | 0.05 | -40.84 | |
| ROIC | 0.04 | 0.02 | -36.96 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.03 | 0.03 | 24.75 | |
| Dividends QOQ | 0.00 | 0.00 | 0.00 | |
| EBIT QOQ | 0.16 | -0.06 | -61.39 | |
| EPS QOQ | 0.55 | -0.39 | -30.06 | |
| FCF QOQ | 0.30 | -0.34 | 12.17 | |
| Revenue QOQ | 0.05 | -0.04 | -6.64 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Weak
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 0.00 | 0.00 | 0.00 | |
| Days Sales Outstanding (DSO) | 78.58 | 83.29 | 5.99 | |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | |
| Debt/Capitalization | 0.69 | 0.68 | -1.71 | |
| Quick Ratio | 0.76 | 0.78 | 3.27 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Bad
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 33.60 | 34.88 | 3.80 | |
| Cash | 8.22 | 8.66 | 5.28 | |
| Capex | -0.98 | -0.80 | 18.99 | |
| Free Cash Flow | 3.12 | 2.07 | -33.63 | |
| Revenue | 21.49 | 20.56 | -4.32 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Weak
Fundamentals
Financial Health
06 - Financial Health ·
Bad